Endothelial and macrophage upregulation of urokinase receptor expression in human renal cell carcinoma

Human Pathology

Volumn 28, Issue 2, 1997, Pages 206-213

  Xu, Yichun ^b   Hagege, Jacqueline ^b   Doublet, Jean Dominique ^b   Callard, Patrice ^b   Sraer, Jean Daniel ^b   Rønne, Ebbe ^b   Rondeau, Eric ^a  

^a HÔPITAL TENON   (France)

^b NONE

Author keywords

carcinoma; kidney; plasminogen activators; urokinase receptor

Indexed keywords

CELL SURFACE RECEPTOR; MESSENGER RNA; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ARTICLE; CANCER INVASION; CAPILLARY ENDOTHELIUM; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY CARCINOMA; MACROPHAGE; PLASMINOGEN ACTIVATION; RECEPTOR UPREGULATION; TUMOR VASCULARIZATION;

EID: 0031036140     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(97)90108-8     Document Type: Article

References (39)

1. Danø K, Andreasen PA, Grøndahl-Hansen J, et al: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266, 1985
2. Montesano R, Pepper MS, Mōhle-Steinlein U, et al: Increased proteolytic activity is responsible for the aberrant morphogenetic behavior of endothelial cells expressing the middle T oncogene. Cell 62:435-445, 1990
3. Ossowski L, Reich E: Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 35:611-619, 1983
4. Ossowski L: Plasminogen activator dependent pathways in the dissemination of human tumor cells in the chick embryo. Cell 52:321-328, 1988
5. Mignatti P, Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73:161-195, 1993
6. Ellis V, Scully MF, Kakkar VV: Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. J Biol Chem 264:2185-2188, 1989
7. Ploug M, Rønne E, Behrendt N, et al: Cellular receptor for urokinase plasminogen activator. J Biol Chem 266:1926-1933, 1991
8. Behrendt N, Ploug M, Patthy L, et al: The ligand-binding domain of the cell surface receptor for urokinase-type plasminogen activator. J Biol Chem 266:7842-7847, 1991
9. 2-terminal domain of urokinase receptor. FEBS Lett 288:233-236, 1991
10. Bianchi E, Cohen RL, Thor AT, et al: The urokinase receptor is expressed in invasive breast cancer but not in normal breast tissue. Cancer Res 54:861-866, 1994
11. Del Vecchio S, Stoppelli MP, Carriero MV, et al: Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography: Comparison with urokinase levels. Cancer Res 53:3198-3206, 1993
12. de Vries TJ, Quax PHA, Denijn M, et al: Plasminogen activators, their inhibitors, and urokinase receptor emerge in late stages of melanocytic tumor progression. Am J Pathol 144:70-81, 1994
13. Sier CF, Quax PH, Vloedgraven HJ, et al: Increased urokinase receptor levels in human gastrointestinal neoplasia and related liver metastases. Invasion Metastasis 13:277-288, 1993
14. Pyke C, Ralfkiaer E, Rønne E, et al: Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer. Histopathology 24:131-138, 1994
15. Grøndahl-Hansen J, Ralfkiaer E, Kirkeby LT, et al: Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol 138:111-117, 1991
16. Pyke C, Kristensen P, Ralfkiaer E, et al: Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am J Pathol 138:1059-1067, 1991
17. Blasi F: Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness. Bioessays 15:105-111, 1993
18. Pyke C, Graem N, Ralfkiaer E, et al: Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma. Cancer Res 53:1911-1915, 1993
19. Sappino AP, Huarte J, Vassalli JD, et al: Sites of synthesis of urokinase and tissue-type plasminogen activators in the murine kidney. J Clin Invest 87:962-970, 1991
20. Dayer JM, Vassalli JD, Bobbitt JL, et al: Calcitonin stimulates plasminogen activator in porcine renal tubular cells: LLCPK1. J Cell Physiol 91:195-200, 1981
21. Pepper M, Matsumoto K, Nakamura T, et al: Hepatocyte growth factor increases urokinase-type plasmnogen activator (u-PA) and u-PA receptor expression in Madin-Darby Canine kidney epithelial cells. J Biol Chem 267:20493-20496, 1992
22. Zollinger HU, Mihatsch MJ: Renal pathology in biopsy: Light, electron and immunofluorescent microscopy and clinical aspects. Berlin, Heidelberg, Springer-Verlag, 1978, p 559
23. Wagner SN, Atkinson MJ, Thanner S, et al: Modulation of urokinase ans urokinase receptor gene expression in human renal cell carcinoma. Am J Pathol 147:183-192, 1995
24. Roldan AL, Cubellis MV, Macucci MT, et al: Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J 9:467-474, 1990
25. Cordell JL, Falini B, Erber WN, et al: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229, 1984
26. Xu Y, Zacharias U, Peraldi MN, et al: Constitutive expression and modulation of the functional thrombin receptor in the human kidney. Am J Pathol 146:101-110, 1995
27. Guesdon JL, Ternynck T, Avrameas S: The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27:1131-1139, 1979
28. Feinberg AP, Vogelstein B: A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
29. Bolon I, Gouyer V, Devouassoux M, et al: Expression of cets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol 147:1298-1310, 1995
30. Pepper MS, Sappino AP, Stōcklin R, et al: Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 122:673-684, 1993
31. Odekon LE, Sato Y, Rifkin DB: Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 150:258-263, 1992
32. Brown LF, Beerse B, Jackman RW, et al: Increased expression of vasvular permeability factor (vascular endothelial growth factor) and its receptor in kidney and bladder carcinomas. Am J Pathol 143:1255-1262, 1993
33. Takahashi A, Sasaki H, Kim SJ, et al: Markedly increased amounts of messenger RNAs for vascular endothelial growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54:4233-4237, 1994
34. Pepper MS, Ferrara N, Orci L, et al: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 181:902-906, 1991
35. O'Reilly MS, Holmgren L, Chen C, et al: Angiostatin induces and sustains dormancy of human primary tumors in mice. Nature Med 2:689-692, 1996
36. Kirchheimer JC, Nong YH, Remold HG: IFN-γ, tumor necrosis factor-a, and urokinase regulate the expression of urokinase receptors on human monocytes. J Immunol 141:4229-4234, 1988
37. Min HY, Semnani R, Mizukami IF, et al: cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator. J Immunol 148:3636-3642, 1992
38. Mantovani A, Bottazzi B, Colotta F, et al: The origin and function of tumor-associated macrophages. Immunol Today 13:265-270, 1992
39. Polverini PJ, Leibovich SJ: Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 51:635-642, 1984